Pylarify dose- radiotherapeutic pharmaceutical

Ended Awarded

Contract number
HT009021FG0910055
Awardee
Awarding agency
Obligated
$13,984

Award facts

Contract value 100% obligated
$13,984.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
Q527 Medical- Nuclear Medicine
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Sterling, VA, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

Sofie Co., a subsidiary of Sofie Biosciences, Inc., has been awarded a firm fixed price blanket purchase agreement call against an unspecified government-wide acquisition contract to deliver Pylarify Dose- Radiotherapeutic Pharmaceutical. The $13,984 contract is with the Defense Health Agency and has a period of performance through September 30, 2021 for product delivery to a location in Sterling, Virginia. No set-aside designation was applied to this award to supply a radiotherapeutic pharmaceutical in support of the Defense Health Agency's medical programs.

Quick answers

Who was awarded contract HT009021FG0910055?

HT009021FG0910055 was awarded to Sofie CO. by Defense Health Agency (Department of Defense) on September 15, 2021.

How much is contract HT009021FG0910055 worth?

The government has obligated $13,984 on HT009021FG0910055.

Is contract HT009021FG0910055 an order under another contract?

Yes. HT009021FG0910055 is a BPA call under HT001421A0014, a blanket purchase agreement.

Was contract HT009021FG0910055 competed?

The extent of competition for HT009021FG0910055 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login